Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors

被引:134
作者
Hahn, CA
Dunn, RH
Logue, PE
King, JH
Edwards, CL
Halperin, EC
机构
[1] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Dept Neuropsychol, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg,Brain Tumor Ctr, Durham, NC 27710 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2003年 / 55卷 / 04期
关键词
brain neoplasms; neuropsychologic testing; quality of life;
D O I
10.1016/S0360-3016(02)04205-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To identify the characteristics of adult patients with newly diagnosed primary brain tumors associated with identifiable deficits in neuropsychologic function to target interventions to improve function and quality of life (QOL). Methods and Materials: Adult patients with newly diagnosed primary brain tumors and their caregivers were enrolled and underwent a battery of standardized neuropsychologic tests, allowing for qualitative and quantitative assessment and sensitive to the effects of the brain tumor, QOL, or caregiver stress. Results: We enrolled 68 patients with no prior radiotherapy. Patients with left hemisphere tumors reported significantly more memory problems and depressive symptoms. They also exhibited poorer attention and were more distractible, with poorer verbal fluency and poorer verbal learning. Patients with glioblastoma multiforme demonstrated poorer psychomotor speed and visual tracking than patients with non-glioblastoma multiforme histologic features. Patients and caregivers; perceived QOL in a similar fashion, with significant correlation between patient and caregiver on hope testing and general QOL on the Linear Analog Self-Assessment Scale. Conclusion: Patients with left hemisphere tumors and glioblastoma multiforme histologic features demonstrated testable differences in neuropsychologic function and QOL that may be amenable to improvement with medical therapy or tailored rehabilitation programs. Caregiver assessments can predict patient QOL, which may be useful in patients with declining status. (C) 2003 Elsevier Science Inc.
引用
收藏
页码:992 / 999
页数:8
相关论文
共 62 条
[1]   NEUROPSYCHOLOGICAL IMPAIRMENTS ASSOCIATED WITH LESIONS CAUSED BY TUMOR OR STROKE [J].
ANDERSON, SW ;
DAMASIO, H ;
TRANEL, D .
ARCHIVES OF NEUROLOGY, 1990, 47 (04) :397-405
[2]   COGNITIVE-FUNCTIONING IN LONG-TERM SURVIVORS OF HIGH-GRADE GLIOMA [J].
ARCHIBALD, YM ;
LUNN, D ;
RUTTAN, LA ;
MACDONALD, DR ;
DELMAESTRO, RF ;
BARR, HWK ;
PEXMAN, JHW ;
FISHER, BJ ;
GASPAR, LE ;
CAIRNCROSS, JG .
JOURNAL OF NEUROSURGERY, 1994, 80 (02) :247-253
[3]   A PROSPECTIVE-STUDY OF SHORT-COURSE RADIOTHERAPY IN POOR-PROGNOSIS GLIOBLASTOMA-MULTIFORME [J].
BAUMAN, GS ;
GASPAR, LE ;
FISHER, BJ ;
HALPERIN, EC ;
MACDONALD, DR ;
CAIRNCROSS, JG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (04) :835-839
[4]  
BECH P, 1986, ACTA PSYCHIAT SCAND, V73, P1
[5]  
Beck A.T., 1987, BECK DEPRESSION INVE
[6]  
CARLSON RH, 2000, ONCOL TIMES, V22, P35
[7]   Depression after stroke and lesion location: a systematic review [J].
Carson, AJ ;
MacHale, S ;
Allen, K ;
Lawrie, SM ;
Dennis, M ;
House, A ;
Sharpe, M .
LANCET, 2000, 356 (9224) :122-126
[8]   SURVIVAL COMPARISON OF RADIOSURGERY-ELIGIBLE AND RADIOSURGERY-INELIGIBLE MALIGNANT GLIOMA PATIENTS TREATED WITH HYPERFRACTIONATED RADIATION-THERAPY AND CARMUSTINE - A REPORT OF RADIATION-THERAPY ONCOLOGY GROUP-83-02 [J].
CURRAN, WJ ;
SCOTT, CB ;
WEINSTEIN, AS ;
MARTIN, LA ;
NELSON, JS ;
PHILLIPS, TL ;
MURRAY, K ;
FISCHBACH, AJ ;
YAKAR, D ;
SCHWADE, JG ;
CORN, B ;
NELSON, DF .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :857-862
[9]   RECURSIVE PARTITIONING ANALYSIS OF PROGNOSTIC FACTORS IN 3 RADIATION-THERAPY ONCOLOGY GROUP MALIGNANT GLIOMA TRIALS [J].
CURRAN, WJ ;
SCOTT, CB ;
HORTON, J ;
NELSON, JS ;
WEINSTEIN, AS ;
FISCHBACH, AJ ;
CHANG, CH ;
ROTMAN, M ;
ASBELL, SO ;
KRISCH, RE ;
NELSON, DF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (09) :704-710
[10]  
CURRAN WJ, 1992, RADIOTHER ONCOL, V24, P511